Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy
Journal article
Hamdy FC. et al, (2024), European Journal of Nuclear Medicine and Molecular Imaging
Artificial Intelligence-Based Quality Assessment of Histopathology Whole-Slide Images within a Clinical Workflow: Assessment of ‘PathProfiler’ in a Diagnostic Pathology Setting
Journal article
Browning L. et al, (2024), Diagnostics, 14, 990 - 990
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.
Journal article
Figiel S. et al, (2023), Molecular cancer, 22
Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types
Journal article
Rao SR. et al, (2023), International Journal of Molecular Sciences, 24, 12722 - 12722
Department Wide Validation in Digital Pathology-Experience from an Academic Teaching Hospital Using the UK Royal College of Pathologists' Guidance.
Journal article
Kelleher M. et al, (2023), Diagnostics (Basel, Switzerland), 13
Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique
Journal article
Bryant RJ. et al, (2023), BJU International, 131, 694 - 704
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of heterogeneity on genomic signature scoring
Journal article
Figiel S. et al, (2023), European Urology, 83, S1793 - S1794
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of heterogeneity on genomic signature scoring
Preprint
Figiel S. et al, (2023)
Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
Journal article
Abd Hamid M. et al, (2020), Cancer Immunology Research, 8, 203 - 216
Results from ADVANCE: A phase I/II open-label non-randomised safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 (VTP-800) vaccine in combination with PD-1 checkpoint blockade in metastatic prostate cancer
Conference paper
Tuthill M. et al, (2020), ANNALS OF ONCOLOGY, 31, S543 - S543
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
Journal article
Li X. et al, (2019), Frontiers in Oncology, 9
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses
Journal article
Abd Hamid M. et al, (2019), Cancer Immunology Research, 7, 1293 - 1306
Non-germ cell testicular tumours: Follow-up and outcomes—A literature review and experience from a UK tertiary referral centre over 13 years.
Conference paper
Scott L. et al, (2018), Journal of Clinical Oncology, 36, e16536 - e16536
VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer.
Conference paper
Redchenko I. et al, (2018), Journal of Clinical Oncology, 36, 3018 - 3018
PD55-08 INTRODUCING MPMRI INTO CONTEMPORARY UK ACTIVE SURVEILLANCE FOR LOCALISED PROSTATE CANCER
Conference paper
Bryant R. et al, (2017), Journal of Urology, 197
Value of Supraregional Multidisciplinary Review for the Contemporary Management of Testicular Tumors
Journal article
Purshouse K. et al, (2017), CLINICAL GENITOURINARY CANCER, 15, 152 - 156
Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.
Journal article
Verrill C. et al, (2016), Oncotarget, 7, 1107 - 1119
Nuclear iASPP may facilitate prostate cancer progression.
Journal article
Morris EV. et al, (2014), Cell death & disease, 5, e1492 - e1492